Clinical trial
OnaBotulinumtoxin-A Effectiveness Evaluation in Chronic Migraine Patients With Short or Long Disease History: an Italian Multicentric Study (the BACH Study)
NCT06537700 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Campus Bio-Medico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OnaBotulinumtoxin-A Effectiveness Evaluation in Chronic Migraine Patients With Short or Long Disease History: an Italian Multicentric Study (the BACH Study)
- Lead sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2024
- Completion date
- December 31, 2025
- Enrollment
- 115 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
migraine